LifeCare Partners
Overview
LifeCare Partners is a Switzerland-based private equity and venture capital firm that provides financing to private and public companies in the life sciences and healthcare sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| NeoPrediX AG | Mar 2021 | Series A | Lead |
| b-rayZ AG | Jul 2022 | Series A | Lead |
| leon-nanodrugs GmbH | Jul 2015 | Series A | Co-investor |
| Leukocare | Jul 2015 | VC Round | Lead |
| Kupando | Mar 2026 | Series A Extension | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is LifeCare Partners based?
LifeCare Partners is headquartered in Basel, Switzerland.
When was LifeCare Partners founded?
LifeCare Partners was founded in 2014.
How many portfolio companies does LifeCare Partners have?
LifeCare Partners has 5 portfolio companies in Caplight's dataset.
What are some companies in LifeCare Partners's portfolio?
Portfolio companies visible on Caplight include NeoPrediX AG, b-rayZ AG, leon-nanodrugs GmbH, Leukocare, Kupando.
What was LifeCare Partners's most recent investment shown here?
LifeCare Partners's most recent investment in this portfolio sample was in Kupando in 2026.
What sectors does LifeCare Partners focus on?
LifeCare Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Enterprise Software, Enterprise Software, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does LifeCare Partners focus on?
LifeCare Partners typically invests at the Early stage.